Skip to main content
SpringerLink
Log in

International Validation of the CLAU-S Quality-of-Life Questionnaire for Use in Patients with Intermittent Claudication

  • Original Research Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Abstract

Background: Intermittent claudication (IC) occurs in patients with peripheral occlusive arterial disease and results in leg pain after walking a certain distance — the claudication distance. Until recently, no specific questionnaire has been available to measure quality of life in patients with IC.

Objectives: To validate the Claudication Scale (CLAU-S) questionnaire in patients in France, the UK, Germany and Belgium.

Methods: Patients completed the CLAU-S questionnaire and provided demographic and clinical data. Pooled data were examined for psychometric and structural validity and test-retest reliability. Structural equation modelling (SEM) was used to confirm that the questionnaire was measuring the causal relationships involved in IC in each of the language groups studied.

Results: Cross-sectional and factor analysis confirmed the validity of the questionnaire in the pooled patient population. Item convergent and discriminant coefficients and internal consistency reliability coefficients met or exceeded standard criteria. Principal component analysis confirmed the factorial structure. The underlying causal relationships in IC were identified using SEM and were consistent in all language groups studied.

Conclusions: The CLAU-S questionnaire has undergone validation in English, French, German and Flemish and has a very satisfactory validity in these languages.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III
Table IV
Table V
Fig. 1

Similar content being viewed by others

References

  1. Kannel WB, Shurtleff D. The Framington study: cigarettes and the development of intermittent claudication. Geriatrics 1973; 28: 61–8

    PubMed  CAS  Google Scholar 

  2. Klannel WB, D’Agostino RB, Wilson PW, et al. Diabetes, fibrinogen, and risk of cardiovascular disease: the Framington experience. Am Heart J 1990; 120: 672–6

    Article  Google Scholar 

  3. Murabito JM, D’Agostino RB, Silbershatz H, et al. Intermittent claudication: a risk profile from The Framington Heart Study. Circulation 1997; 96: 44–9

    Article  PubMed  CAS  Google Scholar 

  4. Johansson J, Egberg N, Hohnsson H, et al. Serum lipoproteins and hemostatic function in intermittent claudication. Arterioscler Thromb 1993; 13: 1441–8

    Article  PubMed  CAS  Google Scholar 

  5. Dormandy JA, Hoare E, Khattab AH, et al. Prognostic significance of rheological and biochemical findings in patients with intermittent claudication. BMJ 1973; 4: 581–3

    Article  PubMed  CAS  Google Scholar 

  6. Molgaard J, Malinow MR, Lassvik C, et al. Hyperhomocyst(e)inaemia: an independent risk factor for intermittent claudication. J Intern Med 1992; 231: 273–9

    Article  PubMed  CAS  Google Scholar 

  7. Arfvidsson B, Karlsson J, Dahllof AG, et al. The impact of intermittent claudication on quality of life evaluated by the Sickness Impact Profile technique. Eur J Clin Invest 1993; 23 (11): 741–5

    Article  PubMed  CAS  Google Scholar 

  8. Pell JP. Impact of intermittent claudication on quality of life. The Scottish Vascular Audit Group. Eur J Vasc Endovasc Surg 1995; 10 (4): 510–1

    Article  Google Scholar 

  9. Currie IC, Wilson YG, Baird RN, et al. Treatment of intermittent claudication: the impact on quality of life. Eur J Vasc Endovasc Surg 1995; 10 (3): 356–61

    Article  PubMed  CAS  Google Scholar 

  10. Khaira HS, Hanger R, Shearman CP. Quality of life in patients with intermittent claudication. Eur J Vasc Endovasc Surg 1996; 12 (4): 511–2

    Article  Google Scholar 

  11. Ponte E, Cattinelli S. quality of life in a group of patients with intermittent claudication. Angiology 1996; 47 (3): 247–51

    Article  PubMed  CAS  Google Scholar 

  12. Finger T, Kirchberger I, Dietze S, et al. Assessing the quality of life of patients with intermittent claudication: psychometric properties of the claudication scale (CLAU-S) [abstract]. Qual Life Res 1995; 4 (5): 427

    Google Scholar 

  13. Dietze S, Kirchberger I, Spengel F, et al. Die claudicatio-scala (CLAU-S) ein krankheitsspezifischer fragebogen zur erfassung der lebensqualitat von patienten mit claudicatio intermitten, entwicklung und validier. Gefäßchirurgie 1997; 2: 11–7

    Article  Google Scholar 

  14. Acquadro C, Jambon B, Ellis D, et al. Language and translation issues. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia: Lippincott-Raven, 1996: 575–85

    Google Scholar 

  15. Spengel F, Brown TM, Dietze S, et al. The claudication scale (CLAU-S): a new disease-specific quality-of-life instrument in intermittent claudication. Dis Manage Health Outcomes 1997; 2 Suppl. 1: 65–70

    Article  Google Scholar 

  16. Liard F, Benichou AC, Gamand S, et al. Les effets du naftidrofuryl sur la qualite de vie. Dis Manage Health Outcomes 1997; 2 Suppl. 1: 71–8

    Article  Google Scholar 

  17. Spengel F, Brown TM, Poth J, et al. Naftidrofuryl can enhance the quality of life in patients with intermittent claudication. Vasa 1999; 28: 207–12

    Article  PubMed  CAS  Google Scholar 

  18. Leidy NK, Revicki DA, Genesté B. Recommendations for evaluating the validity of quality of life claims for labelling and promotion. Values Health 1999; 2 (2): 113–27

    Article  CAS  Google Scholar 

  19. Lohr KN, Aaronson NK, Alonso J, et al. Evaluating quality-of-life and health status instruments: development of scientific review criteria. Clin Ther 1996; 18 (5): 979–92

    Article  PubMed  CAS  Google Scholar 

  20. Van de Vijver F, Leung K. Methods and data analysis for cross-cultural research. Thousand Oaks: Sage Publications, 1997

    Google Scholar 

  21. Hays R, Anderson R, Revicki DA. Assessing reliability and validity of measurement in clinical trials. In: Staquet MJ, Hays RD, Fayers PM, editors. Quality of life assessment in clinical trials. New York: Oxford University Press, 1998: 169–82

    Google Scholar 

  22. Nunnally J. Psychometric theory. New York: McGraw Hill, 1978

    Google Scholar 

  23. Bollen KA. Structural equation with latent variables. New York: J Wiley, 1989

    Google Scholar 

  24. Keller SD, Ware Jr JE, Bentler PM, et al. Use of structural equation modeling to test the construct validity of the SF-36 health survey in 10 countries: results from the IQOLA project. International quality of Life Assessment. J Clin Epidemiol 1998; 51: 1179–88

    Article  PubMed  CAS  Google Scholar 

  25. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures: statistics and strategies for evaluation. Control Clin Trials 1991; 12 (4 Suppl.): S142–58

    Article  Google Scholar 

  26. Lehert P. quality of life assessment in comparative therapeutic trials and causal structure considerations: the particular case of peripheral occlusive arterial disease. Pharmacoeconomics 2001; 19 (2): 121–30

    Article  PubMed  CAS  Google Scholar 

  27. Boccalon H, Lehert P, Mosnier M. Appréciation de la prévalence de l’arthériopathie oblitérante des membres inferieurs en France à l’aide de l’index systolique dans une population à risque vasculaire. J Mal Vasc 2000; 25: 38–46

    PubMed  CAS  Google Scholar 

  28. Balkau B, Vray M, Eschwege E. Epidemiology of peripheral arterial disease. J Cardiovasc Pharmacol 1994; 23 Suppl. 3: S8–16

    Google Scholar 

  29. Leng GC, Lee AJ, Fowkes FG, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996; 25 (6): 1172–81

    Article  PubMed  CAS  Google Scholar 

  30. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA 1995; 273 (1): 59–65

    Article  PubMed  CAS  Google Scholar 

  31. World Health Organisation [online]. Available from URL: http://www.who.int/ [Accessed 2001 May 4]

Download references

Author information

Authors and Affiliations

  1. Mapi Values, Lyon, France

    Patrick Marquis

  2. Lipha s.a., 34 rue Saint Romain, 69379, Lyon Cedex 08, France

    Sylvie Comte

  3. Statistics Department, University of Mons, FuCam, Mons, Belgium and Faculty of Medicine, University of Melbourne, Melbourne, Australia

    Philippe Lehert

Authors
  1. Patrick Marquis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sylvie Comte
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Philippe Lehert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sylvie Comte.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marquis, P., Comte, S. & Lehert, P. International Validation of the CLAU-S Quality-of-Life Questionnaire for Use in Patients with Intermittent Claudication. Pharmacoeconomics 19, 667–677 (2001). https://doi.org/10.2165/00019053-200119060-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-200119060-00005

Keywords

Search

Navigation